• Users Online: 545
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
CASE REPORT
Year : 2017  |  Volume : 3  |  Issue : 2  |  Page : 122-124

Eight months of HeartMate II device support without drug therapy


1 Department of Cardiothoracic Surgery, Mount Sinai Medical Center, New York, NY 10029, USA
2 Mount Sinai Heart, Mount Sinai Medical Center, New York, NY 10029, USA

Correspondence Address:
Anelechi C Anyanwu
Department of Cardiothoracic Surgery, Mount Sinai Medical Center, 1190 Fifth Avenue, New York, NY 10029
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jpcs.jpcs_30_17

Rights and Permissions

Thromboembolic complication rates of 20%–30% were initially a major limitation to the widespread use of left ventricular assist devices. The success of the HeartMate (Thoratec, Corp., Pleasanton, CA, USA) device has been partly due to the reduced incidence of thromboembolic events, although anticoagulation regime has been recommended for this mechanical circulatory support. We here present a case with the placement of HeartMate II in a patient, noncompliant to medical therapy where device worked for 8 months without any anticoagulant or antiplatelet therapy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed666    
    Printed32    
    Emailed0    
    PDF Downloaded58    
    Comments [Add]    

Recommend this journal